Björn Sjöstrand | Chief Executive Officer
Scandinavian Biopharma Holding AB

Björn Sjöstrand, Chief Executive Officer, Scandinavian Biopharma Holding AB

Co-founder and Chief Executive Officer of Scandinavian Biopharma. Björn is former Chief Executive Officer of UniTech Pharma AB (2010-2011), Chief Business Officer of Crucell (2006-2009), a Dutch former listed company with facilities in the Netherlands, Switzerland and USA specializing in vaccines and biopharmaceutical technologies; Chief Executive Officer of Berna Biotech AG (2006-2009), a Swiss company specializing in the development and distribution of viral and bacterial vaccines; Chief Executive Officer of SBL Vaccin AB (2001-2006), a Swedish vaccine company that successfully developed and launched Dukoral®, a travel vaccine. Moreover, throughout the duration of his professional career, he had a seat on several company boards. Björn has also also been an Advisor to the Bill & Melinda Gates Foundation. Other assignment: Chairman of the board Sprint Bioscience.

Appearances:



Day 2 - Wednesday 15th October @ 14:45

Updates on Vaccine Development for E.Coli: ETEC Phase IIb data in travellers and endemic populations

last published: 07/May/25 13:55 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Anna Hindley-Skelt
Anna.Hindley-Skelt@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.